Concepedia

David Chang

DC

44

Publications

4.7K

Citations

27

H-Index

1995

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Virginia Oncology Associates

North Shore University Hospital

Northwell Health

Eastern Virginia Medical School

David Chang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1995–2023

44

Publications

44

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

, , +8

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

Dan G. Blazer, Yoji Kishi, Dipen M. Maru et al. · Journal of Clinical Oncology · 2008 · 593 citations

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases

Dario Ribero, Huamin Wang, Matteo Donadon et al. · Cancer · 2007 · 375 citations · Full text

Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection

Moussa Saleh, James Gabriels, David Chang et al. · Circulation Arrhythmia and Electrophysiology · 2020 · 361 citations · Full text

Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall‐cell lung cancer, or pancreatic cancer

Zhiqiang Meng, Peiying Yang, Yehua Shen et al. · Cancer · 2009 · 283 citations · Full text

Rows per page

1–5 of 44